Zora Biosciences at American Heart Association Scientific Sessions 2010, in Chicago, Illinois, November 2010
Zora Biosciences at Critical Markers of Disease, 8th Annual Biomarkers and Surrogate Endpoints Symposium in Bethesda, MD, September 2010
Zora Biosciences at European Society of Cardiology, ESC Congress 2010, in Stockholm, Sweden, August 2010
Zora Biosciences at European Atherosclerosis Society EAS 2010 Congress in Hamburg, Germany, June 2010
Zora Biosciences at ISSFAL Conference in Maastricht, the Netherlands, May 2010
Zora Biosciences at ASMS Conference on Mass Spectrometry and Allied Topics in Salt Lake City, May 2010
Zora Biosciences at ACC.10 in Atlanta, March 2010
Zora Biosciences at American Heart Association Scientific Conference in Orlando, Florida, November 2009
Zora Biosciences at CMOD in Bethesda, Maryland, October 2009
Zora Biosciences at ESC Congress in Barcelona, August 2009
Zora Biosciences at Vulnerable Plaque meeting, Greece, June 2009
Zora Biosciences at International Symposium on Atherosclerosis in Boston June 2009
Zora Biosciences at ASMS Conference on Mass Spectrometry, Philadelphia, May/June 2009
Zora Biosciences at Frontier Lipidology -meeting, May 2009, in Gothenburg, Sweden
Zora Biosciences at ESAC 2009, April 2009, Denmark
Zora Biosciences at ACC.09, March 2009, in Orlando, USA
Zora is involved in Tekes Pharma programme
Zora is involved in EU FP7 Health -projects
Zora is part of Nordic Centre of Excellence Programme on Food, Nutrition and Health

Back

Zora Biosciences at American Heart Association Scientific Sessions 2010, in Chicago, Illinois, November 2010
Zora Biosciences at Critical Markers of Disease, 8th Annual Biomarkers and Surrogate Endpoints Symposium in Bethesda, MD, September 2010
Zora Biosciences at European Society of Cardiology, ESC Congress 2010, in Stockholm, Sweden, August 2010
Zora Biosciences at European Atherosclerosis Society EAS 2010 Congress in Hamburg, Germany, June 2010
Zora Biosciences at ISSFAL Conference in Maastricht, the Netherlands, May 2010

Archive